BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 29861266)

  • 1. Age of onset of Cannabis use and cognitive function in first-episode non-affective psychosis patients: Outcome at three-year follow-up.
    Setién-Suero E; Martínez-García O; de la Foz VO; Vázquez-Bourgon J; Correa-Ghisays P; Ferro A; Crespo-Facorro B; Ayesa-Arriola R
    Schizophr Res; 2018 Nov; 201():159-166. PubMed ID: 29861266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of current cannabis use on general cognitive function in people with psychotic illness.
    Waterreus A; Badcock JC; Di Prinzio P; Martin-Iverson M; Morgan VA
    Schizophr Res; 2017 Dec; 190():164-171. PubMed ID: 28381332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between cannabis and psychosis: Reasons for use and associated clinical variables.
    Mané A; Fernández-Expósito M; Bergé D; Gómez-Pérez L; Sabaté A; Toll A; Diaz L; Diez-Aja C; Perez V
    Psychiatry Res; 2015 Sep; 229(1-2):70-4. PubMed ID: 26235479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabis use and cognitive function in first episode psychosis: differential effect of heavy use.
    Núñez C; Ochoa S; Huerta-Ramos E; Baños I; Barajas A; Dolz M; Sánchez B; Del Cacho N; ; Usall J
    Psychopharmacology (Berl); 2016 Mar; 233(5):809-21. PubMed ID: 26621349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Course of cannabis use and clinical outcome in patients with non-affective psychosis: a 3-year follow-up study.
    van der Meer FJ; Velthorst E;
    Psychol Med; 2015 Jul; 45(9):1977-88. PubMed ID: 25654244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabis use and cognitive functioning in first-episode schizophrenia patients.
    Rodríguez-Sánchez JM; Ayesa-Arriola R; Mata I; Moreno-Calle T; Perez-Iglesias R; González-Blanch C; Periañez JA; Vazquez-Barquero JL; Crespo-Facorro B
    Schizophr Res; 2010 Dec; 124(1-3):142-51. PubMed ID: 20826079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabis use and first-episode psychosis: relationship with manic and psychotic symptoms, and with age at presentation.
    Stone JM; Fisher HL; Major B; Chisholm B; Woolley J; Lawrence J; Rahaman N; Joyce J; Hinton M; Johnson S; Young AH;
    Psychol Med; 2014 Feb; 44(3):499-506. PubMed ID: 23701858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between cannabis use and cognition in people diagnosed with first-episode psychosis.
    de Vos C; Leopold K; Blanke ES; Siebert S; Baumgardt J; Burkhardt E; Bechdolf A
    Psychiatry Res; 2020 Nov; 293():113424. PubMed ID: 32862065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabis and cognitive performance in psychosis: a cross-sectional study in patients with non-affective psychotic illness and their unaffected siblings.
    Meijer JH; Dekker N; Koeter MW; Quee PJ; van Beveren NJ; Meijer CJ;
    Psychol Med; 2012 Apr; 42(4):705-16. PubMed ID: 21899795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Symptomatology and neuropsychological functioning in cannabis using subjects at ultra-high risk for developing psychosis and healthy controls.
    Korver N; Nieman DH; Becker HE; van de Fliert JR; Dingemans PH; de Haan L; Spiering M; Schmitz N; Linszen DH
    Aust N Z J Psychiatry; 2010 Mar; 44(3):230-6. PubMed ID: 20180725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurocognitive and social cognitive predictors of cannabis use in first-episode psychosis.
    Arnold C; Allott K; Farhall J; Killackey E; Cotton S
    Schizophr Res; 2015 Oct; 168(1-2):231-7. PubMed ID: 26260081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabis abuse is associated with decision-making impairment among first-episode patients with schizophrenia-spectrum psychosis.
    Mata I; Rodríguez-Sánchez JM; Pelayo-Terán JM; Pérez-Iglesias R; González-Blanch C; Ramírez-Bonilla M; Martínez-García O; Vázquez-Barquero JL; Crespo-Facorro B
    Psychol Med; 2008 Sep; 38(9):1257-66. PubMed ID: 18005495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabis use in male and female first episode of non-affective psychosis patients: Long-term clinical, neuropsychological and functional differences.
    Setién-Suero E; Neergaard K; Ramírez-Bonilla M; Correa-Ghisays P; Fañanás L; Crespo-Facorro B; Ayesa-Arriola R
    PLoS One; 2017; 12(8):e0183613. PubMed ID: 28832666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of cannabis use on age of onset and clinical characteristics in first-episode psychotic patients. Data from the Psychosis Incident Cohort Outcome Study (PICOS).
    Tosato S; Lasalvia A; Bonetto C; Mazzoncini R; Cristofalo D; De Santi K; Bertani M; Bissoli S; Lazzarotto L; Marrella G; Lamonaca D; Riolo R; Gardellin F; Urbani A; Tansella M; Ruggeri M;
    J Psychiatr Res; 2013 Apr; 47(4):438-44. PubMed ID: 23290558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stopping cannabis use benefits outcome in psychosis: findings from 10-year follow-up study in the PAFIP-cohort.
    Setién-Suero E; Neergaard K; Ortiz-García de la Foz V; Suárez-Pinilla P; Martínez-García O; Crespo-Facorro B; Ayesa-Arriola R
    Acta Psychiatr Scand; 2019 Oct; 140(4):349-359. PubMed ID: 31381129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-analysis of neurocognition in young psychosis patients with current cannabis use.
    Bogaty SER; Lee RSC; Hickie IB; Hermens DF
    J Psychiatr Res; 2018 Apr; 99():22-32. PubMed ID: 29407284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive functioning in children and adolescents in their first episode of psychosis: differences between previous cannabis users and nonusers.
    de la Serna E; Mayoral M; Baeza I; Arango C; Andrés P; Bombin I; González C; Rapado M; Robles O; Rodríguez-Sánchez JM; Zabala A; Castro-Fornieles J
    J Nerv Ment Dis; 2010 Feb; 198(2):159-62. PubMed ID: 20145493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smoking status and its relationship to demographic and clinical characteristics in first episode psychosis.
    Grossman M; Bowie CR; Lepage M; Malla AK; Joober R; Iyer SN
    J Psychiatr Res; 2017 Feb; 85():83-90. PubMed ID: 27863280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No additive effect of cannabis on cognition in schizophrenia.
    Power BD; Dragovic M; Badcock JC; Morgan VA; Castle D; Jablensky A; Stefanis NC
    Schizophr Res; 2015 Oct; 168(1-2):245-51. PubMed ID: 26235754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporal relationship of first-episode non-affective psychosis with cannabis use: a clinical verification of an epidemiological hypothesis.
    Barrigón ML; Gurpegui M; Ruiz-Veguilla M; Diaz FJ; Anguita M; Sarramea F; Cervilla J
    J Psychiatr Res; 2010 May; 44(7):413-20. PubMed ID: 19900684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.